| Product Code: ETC10573813 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Latvia`s import of DNA vaccines in 2024 saw significant contributions from top exporters including Metropolitan France, Germany, Lithuania, Poland, and the USA. Despite a high Herfindahl-Hirschman Index (HHI) indicating market concentration, the industry experienced a remarkable compound annual growth rate (CAGR) of 43.42% from 2020 to 2024. However, the growth rate in 2024 saw a decline of -57.01% compared to the previous year, signaling potential shifts in market dynamics. Monitoring these trends will be crucial for stakeholders navigating the evolving landscape of DNA vaccine imports in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia DNA Vaccines Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia DNA Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia DNA Vaccines Market - Industry Life Cycle |
3.4 Latvia DNA Vaccines Market - Porter's Five Forces |
3.5 Latvia DNA Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Latvia DNA Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Latvia DNA Vaccines Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 Latvia DNA Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Latvia DNA Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia DNA Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latvia DNA Vaccines Market Trends |
6 Latvia DNA Vaccines Market, By Types |
6.1 Latvia DNA Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia DNA Vaccines Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Latvia DNA Vaccines Market Revenues & Volume, By Recombinant DNA, 2021 - 2031F |
6.1.4 Latvia DNA Vaccines Market Revenues & Volume, By Plasmid DNA, 2021 - 2031F |
6.1.5 Latvia DNA Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Latvia DNA Vaccines Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia DNA Vaccines Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.2.3 Latvia DNA Vaccines Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.2.4 Latvia DNA Vaccines Market Revenues & Volume, By Veterinary Vaccines, 2021 - 2031F |
6.3 Latvia DNA Vaccines Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Latvia DNA Vaccines Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.3.3 Latvia DNA Vaccines Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
6.3.4 Latvia DNA Vaccines Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 Latvia DNA Vaccines Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Latvia DNA Vaccines Market Revenues & Volume, By Plasmid Based, 2021 - 2031F |
6.4.3 Latvia DNA Vaccines Market Revenues & Volume, By Electroporation, 2021 - 2031F |
6.4.4 Latvia DNA Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.5 Latvia DNA Vaccines Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Latvia DNA Vaccines Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.3 Latvia DNA Vaccines Market Revenues & Volume, By Offline Retail, 2021 - 2031F |
6.5.4 Latvia DNA Vaccines Market Revenues & Volume, By B2B Sales, 2021 - 2031F |
7 Latvia DNA Vaccines Market Import-Export Trade Statistics |
7.1 Latvia DNA Vaccines Market Export to Major Countries |
7.2 Latvia DNA Vaccines Market Imports from Major Countries |
8 Latvia DNA Vaccines Market Key Performance Indicators |
9 Latvia DNA Vaccines Market - Opportunity Assessment |
9.1 Latvia DNA Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Latvia DNA Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Latvia DNA Vaccines Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 Latvia DNA Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Latvia DNA Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia DNA Vaccines Market - Competitive Landscape |
10.1 Latvia DNA Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Latvia DNA Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here